News

24th May 2023 by

Biodexa Pharmaceuticals PLC Announces US$3.32 Million Registered Direct Offering

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD …

13th December 2021

IND Application for MTX110 Study in GBM Effective

20th July 2021

Midatech Pharma welcomes Dr Dmitry Zamoryakhin as Chief Scientific Officer

30th June 2021

Targeting Technology offers hope for cancer patients

17th June 2021

Breakthrough data using Q-Sphera technology

25th March 2021

MTX110 Update & Headline Results for 2020

11th December 2020

MTX110 Programmes to be presented at ISPNO 2020

9th December 2020

UK Parliament Highlights Need for New DIPG Treatments

24th November 2020

MTX110 presented at 2020 Annual SNO Conference

27th July 2020

UK Placing to Raise £5.0 million

Publications

14th December 2020

High dose MTX110 (soluble panobinostat) safely administered into the fourth ventricle in a …

Download
14th December 2020

1PNOC015: An Open Label Single Arm Study of MTX110 Delivered by Convection-enhanced Delivery (CED) …

Download
14th December 2020

A Phase I study examining the feasibility of intermittent convection-enhanced delivery (CED) of …

Download
24th November 2020

Conlon: Efficacy of soluble panobinostat (MTX110) in preclinical models of adult glioblastoma

Download
24th November 2020

PNOC015: An Open Label Single Arm Study of MTX110 Delivered by Convection-enhanced Delivery (CED) …

Download
1st June 2018

Singleton et al: The distribution, clearance, and brainstem toxicity of panobinostat administered …

Download
18th March 2017

Printing Particles: Printing particles: A high-throughput technique for the production of uniform, …

Download

Other areas

technology

pipeline

partners